PHARMAPRINT INC
10-K, EX-27.1, 2000-08-17
PHARMACEUTICAL PREPARATIONS
Previous: PHARMAPRINT INC, 10-K, EX-23.2, 2000-08-17
Next: PMI GROUP INC, 8-K, 2000-08-17



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               MAR-31-2000
<CASH>                                         302,633
<SECURITIES>                                         0
<RECEIVABLES>                                  742,888
<ALLOWANCES>                                   742,888
<INVENTORY>                                  1,741,773
<CURRENT-ASSETS>                             2,379,942
<PP&E>                                         698,255
<DEPRECIATION>                               (498,255)
<TOTAL-ASSETS>                               2,579,942
<CURRENT-LIABILITIES>                       14,453,792
<BONDS>                                        137,352
                                0
                                          7
<COMMON>                                        16,831
<OTHER-SE>                                (12,028,040)
<TOTAL-LIABILITY-AND-EQUITY>                 2,579,942
<SALES>                                      6,492,868
<TOTAL-REVENUES>                             6,492,868
<CGS>                                       11,516,696
<TOTAL-COSTS>                               11,516,696
<OTHER-EXPENSES>                            24,348,076
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             223,000
<INCOME-PRETAX>                           (27,595,904)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (27,595,904)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (27,595,904)
<EPS-BASIC>                                     (1.92)
<EPS-DILUTED>                                   (1.92)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission